|
PSMC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.01110000050708E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.51258999999682E-05 |
| Normal-vs-Stage2 |
4.376800E-01 |
| Normal-vs-Stage3 |
1.920150E-02 |
| Normal-vs-Stage4 |
5.61729999999372E-05 |
| Stage1-vs-Stage2 |
1.287980E-02 |
| Stage1-vs-Stage3 |
1.764970E-01 |
| Stage1-vs-Stage4 |
4.555000E-01 |
| Stage2-vs-Stage3 |
2.478200E-01 |
| Stage2-vs-Stage4 |
5.220600E-03 |
| Stage3-vs-Stage4 |
6.163500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.7073899999942E-05 |
| Normal-vs-AfricanAmerican |
8.34040000000646E-05 |
| Normal-vs-Asian |
6.699200E-01 |
| Caucasian-vs-AfricanAmerican |
6.725900E-02 |
| Caucasian-vs-Asian |
6.871800E-01 |
| AfricanAmerican-vs-Asian |
2.508000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.1114999999905E-05 |
| Normal-vs-Female |
3.50530000000626E-05 |
| Male-vs-Female |
7.585400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.730300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.87756999999733E-05 |
| Normal-vs-Age(61-80Yrs) |
3.632300E-04 |
| Normal-vs-Age(81-100Yrs) |
5.580000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.746600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.214400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.053800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.499200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.761000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.293400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.37539999956316E-07 |
| Normal-vs-Grade 2 |
1.79765999999137E-05 |
| Normal-vs-Grade 3 |
1.019090E-03 |
| Normal-vs-Grade 4 |
1.151900E-02 |
| Grade 1-vs-Grade 2 |
1.272000E-01 |
| Grade 1-vs-Grade 3 |
1.659630E-02 |
| Grade 1-vs-Grade 4 |
8.322500E-02 |
| Grade 2-vs-Grade 3 |
1.614250E-01 |
| Grade 2-vs-Grade 4 |
6.316400E-01 |
| Grade 3-vs-Grade 4 |
5.914000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.71594999999192E-05 |
| Normal-vs-ccB subtype |
1.332630E-01 |
| ccA subtype-vs-ccB subtype |
6.414100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.805800E-04 |
| Normal-vs-N1 |
6.758400E-01 |
| N0-vs-N1 |
1.304330E-02 |
|
|
